However, a few recent studies have demonstrated that Sirt4 can also be upregulated in some tumors and can exert oncogenic properties by regulating the stress responses of cancer cells and preparing them to gain selective advantages, including resistance to anti-tumor treatments (2, 4). This evidence concerns the gene SIRT4 and neoplasm.